aripiprazole and pregnancy

New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine

No major malformations were associated with olanzapine exposure during the first trimester of pregnancy.

By |2023-03-02T15:52:24-04:00March 1st, 2023|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine

New Research from the CWMH: No Increase in Major Malformations in Children Prenatally Exposed to Aripiprazole

Despite the increasing use of the newer atypical or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including psychotic disorders, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little [...]

By |2021-03-29T13:17:38-04:00March 30th, 2021|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: No Increase in Major Malformations in Children Prenatally Exposed to Aripiprazole

New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2021-03-29T10:51:11-04:00June 3rd, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics
Go to Top